Author:

–

Date: 25 September 2001

Abstract:

Itraconazole is a broad spectrum triazole antifungal agent, for the treatment of fungal skin infections, onchomycosis, candidiasis and systemic fungal infections. Oral formulations have been licensed since 1989 and an intravenous (IV) formulation has been marketed in the UK since early 2001. Approximately 67 million patients have received itraconazole worldwide.

Link to DOI

Download the full article (Disclaimer)

This manuscript library of ~16,000 articles (1729-2024) related to Aspergillus and aspergillosis is intended for individual study only, and is provided as contribution to global understanding of the topic. Please refer to the publisher’s guidance about any other usage.

I understand (click to accept and view download link)

---